Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of <i>Ginkgo biloba</i> extract EGb 761<sup>®</sup> in cognitive impairment associated with post COVID-19 syndrome-the EGb COCOS protocol.

Frontiers in human neuroscience·2026
Same author

Appropriate use recommendations of the Spanish Society of Neurology's Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease.

Neurologia·2026
Same author

Comprehensive neuropsychological assessment and FDG-PET imaging in patients with RFC1-related disorder.

Parkinsonism & related disorders·2026
Same author

Long-term effect of transcranial magnetic stimulation and transcranial electrical stimulation in primary progressive aphasia: study protocol for a randomised, double-blind clinical trial (RECONNECT-PLUS).

BMJ open·2026
Same author

Enhancing Catalyst Stability for Magnetically Induced Aqueous Catalysis: Functionalization with a Hydrosoluble Zwitterionic Amidinate Ligand.

ChemSusChem·2026
Same author

Cognitive characterization of the behavioral variant of frontotemporal dementia using the Neuronorma battery.

Journal of Alzheimer's disease : JAD·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

José Antonio Allué1, Leticia Sarasa1, María Pascual-Lucas1

  • 1Araclon Biotech, Zaragoza, Zaragoza, Spain.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

这项研究开发了一种血生物标记模型,以预测粉样蛋白在大脑中的积累,这对于阿尔茨海默病的诊断至关重要. 该模型使用血pTau-217,Aβ42/Aβ40,APOE基因型和年龄,在预测粉样蛋白状况方面显示出高准确性.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物 生物标志物
  • 阿尔茨海默氏症疾病研究研究

背景情况:

  • 早期识别大脑中的粉样β (Aβ) 积累对于阿尔茨海默病 (AD) 的诊断和管理至关重要.
  • 血生物标志物为检测Aβ积累提供了一种有前途的非侵入性方法.
  • 目前的诊断方法通常依赖于更具侵入性的程序,如CSF分析.

研究的目的:

  • 使用血生物标志物开发和验证大脑粉样蛋白积累的预测模型.
  • 评估开发模型的诊断性能和临床实用性.
  • 探索用于非侵入性AD诊断的多分析体血方法的潜力.

主要方法:

  • 使用血pTau-217,Aβ42/Aβ40比率,APOE基因型和患者年龄构建了一个后勤回归模型.
  • 用脑脊液 (CSF) 的Aβ42/Aβ40测量来确定粉样状况.
  • 在54名患者的队列中,使用AIC,精度,AUC,灵敏度,特异性和预测值来评估模型性能.

主要成果:

  • 开发的模型实现了0.97的AUC和93%的准确性在预测粉样蛋白在大脑中的积累.
  • 该模型显示了高的正 (96%) 和负 (89%) 预测值.
  • 这些发现表明,在初步评估中不需要双重切断的情况下,可能会采用简化,非侵入性诊断方法.

结论:

  • 一个基于等离子体的模型整合了pTau-217,Aβ42/Aβ40,APOE基因型和年龄,有效地预测了粉样蛋白在大脑中的积累.
  • 这种非侵入性方法显示出显著的统计性能和临床相关性,用于推进AD诊断.
  • 需要在更大的队列中进一步验证,以确认这些血生物标志物的广泛临床适用性.